A transformative leader for more than two decades, Marshall will transition to advisory role
Site Search
Showing 1 - 5 of 5 results
News
|
March 6, 2024
|
3 min read
The funding will help support research into the development of potential new modulator therapies for people with cystic fibrosis with an F508del mutation.
News
|
March 7, 2024
|
2 min read
Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
News
|
March 18, 2024
|
2 min read
This year’s program marked the largest in-person advocacy event in the Foundation’s history.
News
|
March 19, 2024
|
3 min read
Revised approach to lung function reporting is shown to be more scientifically accurate and may reduce health disparities.
News
|
April 2, 2024
|
5 min read